<table class="naaccr-summary-table naaccr-borders">
  <tr>
    <th class="naaccr-summary-header naaccr-borders">Item #</th>
    <th class="naaccr-summary-header naaccr-borders">Length</th>
    <th class="naaccr-summary-header naaccr-borders">Source of Standard</th>
    <th class="naaccr-summary-header naaccr-borders">Year Implemented</th>
    <th class="naaccr-summary-header naaccr-borders">Version Implemented</th>
    <th class="naaccr-summary-header naaccr-borders">Year Retired</th>
    <th class="naaccr-summary-header naaccr-borders">Version Retired</th>
  </tr>
  <tr>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">762</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">SEER</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">2018</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">16</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
  </tr>
</table>

<br/><strong>NAACCR XML</strong>: Tumor.derivedSummaryStage2018<br/><br/>
<strong>Alternate Names</strong>
<br/>&nbsp;&nbsp;&nbsp;Derived SS2018

<div class='content chap10-para-head'><strong>Description</strong></div>
<div class='content chap10-para'>
<p>Derived Summary Stage 2018 is derived using the EOD data collection system (EOD Primary Tumor [772], EOD Regional Nodes [774] and EOD Mets [776]) algorithm. Other data items may be included in the derivation process. Effective for cases diagnosed 1/1/2018+.</p>

</div>

<div class='content chap10-para-head'><strong>Rationale</strong></div>
<div class='content chap10-para'>
<p>The SEER program has collected staging information on cases since its inception in 1973. Summary Stage groups cases into broad categories of in situ, local, regional, and distant. Summary Stage can be used to evaluate disease spread at diagnosis, treatment patterns and outcomes over time.<br />
Â <br />
Derived Summary Stage 2018 [762] is only available at the central registry level.</p>

</div>


<div class='content chap10-para'>
<p><em>Note</em>: This data item was included in Standards Volume II, Version 16; however, it was not implemented until 2018.</p>

</div>

<div class='content chap10-para'><p><strong>Codes</strong></p>
</div>
<table>
        <tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>In situ</td></tr>
        <tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Localized</td></tr>
        <tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Regional, direct extension only</td></tr>
        <tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Regional, regional lymph nodes only</td></tr>
        <tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Regional, direct extension and regional lymph nodes</td></tr>
        <tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Distant</td></tr>
        <tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Benign, borderline</td></tr>
        <tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown if extension or metastasis (unstaged, unknown, or unspecified)  
 Death certificate only case</td></tr>
</table>

